"Prevalence of inhibitors in a population of 1280 Hemophilia A patients in Iran "

Development of inhibitor to factor VIII is the most serious complication of hemophilia therapy. To determine the prevalence of inhibitors in Iran hemophilia A patients exposed to blood products, 1280 hemophilia A patients (age range 9 months-84 years) were evaluated. All patients received several bl...

Full description

Bibliographic Details
Main Authors: Sharifian R, Hosseini M, Safai R, Tugeh Gh, Ehsani AH, Lak M, Jazebi M
Format: Article
Language:English
Published: Tehran University of Medical Sciences 2003-03-01
Series:Acta Medica Iranica
Subjects:
Online Access:https://acta.tums.ac.ir/index.php/acta/article/view/2636